advertisement
11.1 General management, indication (26)
Showing records 1 to 25
Display all abstracts in classification 11.1 General management, indication
Search within classification 11.1 General management, indication91905 Glaucoma
Kang JM
The Medical clinics of North America 2021; 105: 493-510
92168 New considerations for the clinical efficacy of old and new topical glaucoma medications
MacIver S
Clinical and Experimental Optometry 2021; 104: 350-366
92438 What Is New in Glaucoma: From Treatment to Biological Perspectives
Nuzzi R
Journal of Ophthalmology 2021; 2021: 5013529
92609 The future is old - Patients with topical ocular hypotensive treatment in the Nordic region between 2008 and 2017 with projections for 2040
Bro T
Acta Ophthalmologica 2021; 99: e1442-e1448
92362 What Do We Really Know about the Effectiveness of Glaucoma Interventions?: An Overview of Systematic Reviews
Qureshi R
Ophthalmology. Glaucoma 2021; 0:
91911 Advances in medical therapy for glaucoma
Ostler E
Current Opinions in Ophthalmology 2021; 32: 129-133
92479 Optical Coherence Tomography Angiography Vessel Density Changes in Normal-tension Glaucoma Treated with Carteolol, Brimonidine, or Dorzolamide
Lin YH
Journal of Glaucoma 2021; 30: 690-696
92438 What Is New in Glaucoma: From Treatment to Biological Perspectives
Marolo P
Journal of Ophthalmology 2021; 2021: 5013529
91905 Glaucoma
Tanna AP
The Medical clinics of North America 2021; 105: 493-510
92609 The future is old - Patients with topical ocular hypotensive treatment in the Nordic region between 2008 and 2017 with projections for 2040
Wickström K
Acta Ophthalmologica 2021; 99: e1442-e1448
92479 Optical Coherence Tomography Angiography Vessel Density Changes in Normal-tension Glaucoma Treated with Carteolol, Brimonidine, or Dorzolamide
Su WW
Journal of Glaucoma 2021; 30: 690-696
91911 Advances in medical therapy for glaucoma
Rhee D
Current Opinions in Ophthalmology 2021; 32: 129-133
92168 New considerations for the clinical efficacy of old and new topical glaucoma medications
Stout N
Clinical and Experimental Optometry 2021; 104: 350-366
92362 What Do We Really Know about the Effectiveness of Glaucoma Interventions?: An Overview of Systematic Reviews
Azuara-Blanco A
Ophthalmology. Glaucoma 2021; 0:
92609 The future is old - Patients with topical ocular hypotensive treatment in the Nordic region between 2008 and 2017 with projections for 2040
Lindén C
Acta Ophthalmologica 2021; 99: e1442-e1448
91911 Advances in medical therapy for glaucoma
Burney E
Current Opinions in Ophthalmology 2021; 32: 129-133
92168 New considerations for the clinical efficacy of old and new topical glaucoma medications
Ricci O
Clinical and Experimental Optometry 2021; 104: 350-366
92479 Optical Coherence Tomography Angiography Vessel Density Changes in Normal-tension Glaucoma Treated with Carteolol, Brimonidine, or Dorzolamide
Huang SM
Journal of Glaucoma 2021; 30: 690-696
92438 What Is New in Glaucoma: From Treatment to Biological Perspectives
Nuzzi A
Journal of Ophthalmology 2021; 2021: 5013529
92362 What Do We Really Know about the Effectiveness of Glaucoma Interventions?: An Overview of Systematic Reviews
Michelessi M
Ophthalmology. Glaucoma 2021; 0:
92479 Optical Coherence Tomography Angiography Vessel Density Changes in Normal-tension Glaucoma Treated with Carteolol, Brimonidine, or Dorzolamide
Chuang LH
Journal of Glaucoma 2021; 30: 690-696
92362 What Do We Really Know about the Effectiveness of Glaucoma Interventions?: An Overview of Systematic Reviews
Virgili G
Ophthalmology. Glaucoma 2021; 0:
91911 Advances in medical therapy for glaucoma
Sozeri Y
Current Opinions in Ophthalmology 2021; 32: 129-133
92362 What Do We Really Know about the Effectiveness of Glaucoma Interventions?: An Overview of Systematic Reviews
Barbosa Breda J
Ophthalmology. Glaucoma 2021; 0:
92479 Optical Coherence Tomography Angiography Vessel Density Changes in Normal-tension Glaucoma Treated with Carteolol, Brimonidine, or Dorzolamide
Chen LC
Journal of Glaucoma 2021; 30: 690-696